Robert Langer

Robert Langer is currently serving on the respective boards of directors of Abpro Corporation, Frequency Therapeutics, Inc., Rubius Therapeutics, Inc., Moderna, Inc., and Puretech Health plc. He received his Bachelor’s Degree from Cornell University and his Sc.D. from the Massachusetts Institute of Technology, both in Chemical Engineering.